Selected research
Industry Research
Calcitriol Injection Industry Research Report 2026
Market perspective
The global Calcitriol Injection market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Calcitriol Injection is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Calcitriol Injection is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Calcitriol Injection is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Calcitriol Injection include Abbott, Fresenius Kabi, Abbvie, Teva Parenteral Medicines, Sterimax Inc, NEPHRX, LLC, Gland Pharma Limited, AMERICAN REGENT, INC and Akorn Pharmaceuticals, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Calcitriol Injection market in terms of revenue (US$ million) and, where applicable, sales volume (K L), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K L) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Calcitriol Injection Market by Company
Abbott
Fresenius Kabi
Abbvie
Teva Parenteral Medicines
Sterimax Inc
NEPHRX, LLC
Gland Pharma Limited
AMERICAN REGENT, INC
Akorn Pharmaceuticals
Calcitriol Injection Segment by Type
1 mcg/mL
2 mcg/mL
Calcitriol Injection Segment by Application
Hospital
Clinic
Calcitriol Injection Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Calcitriol Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Calcitriol Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Calcitriol Injection.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Calcitriol Injection manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Calcitriol Injection by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Calcitriol Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 1 mcg/mL
- 2 mcg/mL
Applications
- Hospital
- Clinic
Companies covered
- Abbott
- Fresenius Kabi
- Abbvie
- Teva Parenteral Medicines
- Sterimax Inc
- NEPHRX, LLC
- Gland Pharma Limited
- AMERICAN REGENT, INC
- Akorn Pharmaceuticals
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Calcitriol Injection Market Size (2021-2032)
- 2.2.2 Global Calcitriol Injection Sales (2021-2032)
- 2.2.3 Global Calcitriol Injection Market Average Price (2021-2032)
- 2.3 Calcitriol Injection by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 1 mcg/mL
- 2.3.3 2 mcg/mL
- 2.4 Calcitriol Injection by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Hospital
- 2.4.3 Clinic
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Calcitriol Injection Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Calcitriol Injection Sales (K L) of Manufacturers (2021-2026)
- 3.3 Global Calcitriol Injection Revenue of Manufacturers (2021-2026)
- 3.4 Global Calcitriol Injection Average Price by Manufacturers (2021-2026)
- 3.5 Global Calcitriol Injection Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Calcitriol Injection, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Calcitriol Injection, Product Type & Application
- 3.8 Global Manufacturers of Calcitriol Injection, Established Date
- 3.9 Global Calcitriol Injection Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Abbott
- 4.1.1 Abbott Company Information
- 4.1.2 Abbott Business Overview
- 4.1.3 Abbott Calcitriol Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Abbott Calcitriol Injection Product Portfolio
- 4.1.5 Abbott Recent Developments
- 4.2 Fresenius Kabi
- 4.2.1 Fresenius Kabi Company Information
- 4.2.2 Fresenius Kabi Business Overview
- 4.2.3 Fresenius Kabi Calcitriol Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Fresenius Kabi Calcitriol Injection Product Portfolio
- 4.2.5 Fresenius Kabi Recent Developments
- 4.3 Abbvie
- 4.3.1 Abbvie Company Information
- 4.3.2 Abbvie Business Overview
- 4.3.3 Abbvie Calcitriol Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Abbvie Calcitriol Injection Product Portfolio
- 4.3.5 Abbvie Recent Developments
- 4.4 Teva Parenteral Medicines
- 4.4.1 Teva Parenteral Medicines Company Information
- 4.4.2 Teva Parenteral Medicines Business Overview
- 4.4.3 Teva Parenteral Medicines Calcitriol Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Teva Parenteral Medicines Calcitriol Injection Product Portfolio
- 4.4.5 Teva Parenteral Medicines Recent Developments
- 4.5 Sterimax Inc
- 4.5.1 Sterimax Inc Company Information
- 4.5.2 Sterimax Inc Business Overview
- 4.5.3 Sterimax Inc Calcitriol Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Sterimax Inc Calcitriol Injection Product Portfolio
- 4.5.5 Sterimax Inc Recent Developments
- 4.6 NEPHRX, LLC
- 4.6.1 NEPHRX, LLC Company Information
- 4.6.2 NEPHRX, LLC Business Overview
- 4.6.3 NEPHRX, LLC Calcitriol Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 NEPHRX, LLC Calcitriol Injection Product Portfolio
- 4.6.5 NEPHRX, LLC Recent Developments
- 4.7 Gland Pharma Limited
- 4.7.1 Gland Pharma Limited Company Information
- 4.7.2 Gland Pharma Limited Business Overview
- 4.7.3 Gland Pharma Limited Calcitriol Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Gland Pharma Limited Calcitriol Injection Product Portfolio
- 4.7.5 Gland Pharma Limited Recent Developments
- 4.8 AMERICAN REGENT, INC
- 4.8.1 AMERICAN REGENT, INC Company Information
- 4.8.2 AMERICAN REGENT, INC Business Overview
- 4.8.3 AMERICAN REGENT, INC Calcitriol Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 AMERICAN REGENT, INC Calcitriol Injection Product Portfolio
- 4.8.5 AMERICAN REGENT, INC Recent Developments
- 4.9 Akorn Pharmaceuticals
- 4.9.1 Akorn Pharmaceuticals Company Information
- 4.9.2 Akorn Pharmaceuticals Business Overview
- 4.9.3 Akorn Pharmaceuticals Calcitriol Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Akorn Pharmaceuticals Calcitriol Injection Product Portfolio
- 4.9.5 Akorn Pharmaceuticals Recent Developments
5 Global Calcitriol Injection Market Scenario by Region
- 5.1 Global Calcitriol Injection Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Calcitriol Injection Sales by Region: 2021-2032
- 5.2.1 Global Calcitriol Injection Sales by Region: 2021-2026
- 5.2.2 Global Calcitriol Injection Sales by Region: 2027-2032
- 5.3 Global Calcitriol Injection Revenue by Region: 2021-2032
- 5.3.1 Global Calcitriol Injection Revenue by Region: 2021-2026
- 5.3.2 Global Calcitriol Injection Revenue by Region: 2027-2032
- 5.4 North America Calcitriol Injection Market Facts & Figures by Country
- 5.4.1 North America Calcitriol Injection Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Calcitriol Injection Sales by Country (2021-2032)
- 5.4.3 North America Calcitriol Injection Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Calcitriol Injection Market Facts & Figures by Country
- 5.5.1 Europe Calcitriol Injection Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Calcitriol Injection Sales by Country (2021-2032)
- 5.5.3 Europe Calcitriol Injection Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.6 Asia Pacific Calcitriol Injection Market Facts & Figures by Country
- 5.6.1 Asia Pacific Calcitriol Injection Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Calcitriol Injection Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Calcitriol Injection Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Calcitriol Injection Market Facts & Figures by Country
- 5.7.1 South America Calcitriol Injection Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Calcitriol Injection Sales by Country (2021-2032)
- 5.7.3 South America Calcitriol Injection Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.7.7 Colombia
- 5.8 Middle East and Africa Calcitriol Injection Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Calcitriol Injection Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Calcitriol Injection Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Calcitriol Injection Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Calcitriol Injection Sales by Type (2021-2032)
- 6.1.1 Global Calcitriol Injection Sales by Type (2021-2032) & (K L)
- 6.1.2 Global Calcitriol Injection Sales Market Share by Type (2021-2032)
- 6.2 Global Calcitriol Injection Revenue by Type (2021-2032)
- 6.2.1 Global Calcitriol Injection Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Calcitriol Injection Revenue Market Share by Type (2021-2032)
- 6.3 Global Calcitriol Injection Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Calcitriol Injection Sales by Application (2021-2032)
- 7.1.1 Global Calcitriol Injection Sales by Application (2021-2032) & (K L)
- 7.1.2 Global Calcitriol Injection Sales Market Share by Application (2021-2032)
- 7.2 Global Calcitriol Injection Revenue by Application (2021-2032)
- 7.2.1 Global Calcitriol Injection Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Calcitriol Injection Revenue Market Share by Application (2021-2032)
- 7.3 Global Calcitriol Injection Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Calcitriol Injection Value Chain Analysis
- 8.1.1 Calcitriol Injection Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Calcitriol Injection Production Mode & Process
- 8.2 Calcitriol Injection Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Calcitriol Injection Distributors
- 8.2.3 Calcitriol Injection Customers
9 Global Calcitriol Injection Analyzing Market Dynamics
- 9.1 Calcitriol Injection Industry Trends
- 9.2 Calcitriol Injection Industry Drivers
- 9.3 Calcitriol Injection Industry Opportunities and Challenges
- 9.4 Calcitriol Injection Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst